Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective

BACKGROUND: Traditional clinical trials require tests and procedures that are administered in centralized clinical research sites, which are beyond the standard of care that patients receive for their rare and chronic diseases. The limited number of rare disease patients scattered around the world m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadessi, Mercedeh, Di, Junrui, Wang, Chenkun, Toyoizumi, Kiichiro, Shao, Nan, Mei, Chaoqun, Demanuele, Charmaine, Tang, Rui (Sammi), McMillan, Gianna, Beckman, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088572/
https://www.ncbi.nlm.nih.gov/pubmed/37041605
http://dx.doi.org/10.1186/s13023-023-02693-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088572/
https://www.ncbi.nlm.nih.gov/pubmed/37041605
http://dx.doi.org/10.1186/s13023-023-02693-7

Ejemplares similares